5. Pulmonary vascular diseases Flashcards
1
Q
Types of pulmonary vascular diseases
A
- Pulmonary edema
- Pulmonary hypertension
- Pulmonary embolism
- Diffuse pulmonary haemorrhage syndromes
2
Q
Causes of pulmonary edema
A
- Hemodynamic causes
- Increased capillary hydrostatic pressure (left-sided heart failure, volume overload, pulmonary vein obstruction)
- Decreased capillary oncotic pressure (hypoalbuminemia, nephrotic syndrome, liver disease, protein-losing enteropathies)
- Lymphatic obstruction - Microvascular injury
- Infections (pneumonia, septicaemia)
- Inhaled toxic gases
- Drugs & chemicals
- Shock, trauma, radiation - Others (of unknown mechanisms)
- High altitudes
- Neurogenic (CNS trauma)
3
Q
Morphology of pulmonary edema
A
- Interstitial edema
- Edematous widening of alveolar septa
- Accumulation of edema fluid in alveolar spaces
- Hemosiderin-laden macrophages
4
Q
Causes of pulmonary hypertension
A
- Primary idiopathic pulmonary hypertension
- Most common in women, 20-40 years old - Left-sided heart disease
- Left-sided heart failure, mitral stenosis
- Results in chronic venous congestion and consequent increase in pulmonary arterial pressure - Congenital left-to-right shunts
- Increase pulmonary blood flow increases shear stress on pulmonary vasculature, promoting endothelial dysfunction - Lung disease
- Chronic obstructive lung disease (damaged vasculature, pulmonary hypoxia)
- Lung fibrosis (damaged vasculature) - Recurrent pulmonary thromboembolism
- Increase pulmonary vascular resistance over time - Pulmonary hypoxia
- Causes hypoxic vasoconstriction of pulmonary vasculature, increasing vascular resistance - Connective tissue disease
- Most notably systemic sclerosis
- May involve pulmonary vasculature, leading to inflammation, intimal fibrosis and medial hypertrophy
5
Q
Pathogenesis of pulmonary hypertension
A
- Process which initiates the disorder results in endothelial dysfunction which plays central role in the development of pulmonary hypertension in the following ways:
- Decreased nitric oxide production & increased endothelin release → promote vasoconstriction
- Decreased production of anti-thrombotic factors (e.g. prostacyclin) & endothelial activation → promote thrombosis
- Production of cytokines & growth factors locally promote migration & proliferation of vascular smooth muscle cells & elaboration of extracellular matrix - Pulmonary vasospasm may also contribute in some cases
- Ingestion of certain plant substances or medicines may also lead to pulmonary hypertension
6
Q
Morphology of pulmonary hypertension
A
- Atherosclerosis (of pulmonary artery & its major branches)
- Medial hypertrophy (increased thickness of smooth muscle & intimal proliferation)
- Luminal occlusion (due to intimal fibrosis)
- Plexiform lesions (nodular lesions of interlacing blood vessels, seen in small arteries of advanced pulmonary hypertension)
- Fibrinoid necrosis
- Hemorrhage (due to rupture of vessels)
7
Q
Pathological effects and complications of pulmonary hypertrophy
A
Cor pulmonale
8
Q
Causes of pulmonary embolism
A
- Thrombus in the deep veins of the leg (95%)
- Hypercoagulable states
- Indwelling central venous lines
9
Q
Pathological effects & complications of pulmonary embolism
A
- Respiratory compromise
- Increased physiological dead space (areas of lung which are ventilated but not perfused) - Hemodynamic compromise
- Pulmonary hypertension: multiple recurrent small
emboli progressively increases pulmonary vascular resistance; may lead to the development of chronic cor pulmonale
- Acute cor pulmonale: large embolus obstructing the main pulmonary artery; may lead to sudden death (saddle embolus = large embolus lodged at the bifurcation of pulmonary trunk)
- Pulmonary infarct: rarely occurs as bronchial arterial supply is usually sufficient; appears as a wedge shape pale area with apex pointing towards hilum
10
Q
Definition of diffuse pulmonary haemorrhage syndrome
A
Hemorrhage from the lung as a dramatic complication of some interstitial lung disorders
11
Q
Types of diffuse pulmonary haemorrhage syndrome
A
- Goodpasture syndrome
2. Pulmonary vasculitis
12
Q
Goodpasture syndrome
A
- Type II hypersensitivity disorder caused by autoantibodies against the non-collagenous domain of the alpha3 chain of collagen IV (a constituent of alveolar & glomerular basement membranes)
- Results in a necrotizing hemorrhagic interstitial pneumonitis
- Also results in a proliferative & usually rapidly progressive glomerulonephritis
13
Q
Pulmonary vasculitis
A
Wegener granulomatosis, microscopic polyangiitis